The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
p38 Pathway Kinases as Anti-inflammatory Drug Targets
Abstract
Mitogen-activated protein kinases (MAPK) are intracellular signaling molecules involved in cytokine synthesis. Several classes of mammalian MAPK have been identified, including extracellular signal-regulated kinase, c-jun N-terminal kinase, and p38 MAP kinase. p38α is a key MAPK involved in tumor necrosis factor α and other cytokine production, as well as enzyme induction (cyclooxygenase-2, inducible nitric oxide synthase, and matrix metalloproteinases) and adhesion molecule expression. An understanding of the broad biologic and pathophysiological roles of p38 MAPK family members has grown significantly over the past decade, as has the complexity of the signaling network leading to their activation. Downstream substrates of MAPK include other kinases ( e.g., mitogen-activated protein-kinase-activated protein kinase 2) and factors that regulate transcription, nuclear export, and mRNA stability and translation. The high-resolution crystal structure of p38α has led to the design of selective inhibitors that have good pharmacological activity. Despite the strong rationale for MAPK inhibitors in human disease, direct proof of concept in the clinic has yet to be demonstrated, with most compounds demonstrating dose-limiting adverse effects. The role of MAPK in inflammation makes them attractive targets for new therapies, and efforts are continuing to identify newer, more selective inhibitors for inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AP-1 as a regulator of cell life and death
Shaulian, E., & Karin, M. (2002) · Nature Cell Biology · doi:10.1038/ncb0502-e131 · Cited by 2,961 · cited 1×
“The JNK family of enzymes are inflammation- and stressactivated MAPKs involved in the regulation of cell proliferation, survival, and apoptosis (Shaulian and Karin, 2002).”
BackgroundIndependent Human MAP-Kinase Signal Transduction Pathways Defined by MEK and MKK Isoforms
Dérijard, B., Raingeaud, J., Barrett, T., Wu, I.-H., Han, J., Ulevitch, R. J., & Davis, R. J. (1995) · Science · doi:10.1126/science.7839144 · Cited by 1,555 · cited 9×
“The protein kinases MKK3 and MKK6 specifically activate the p38 MAPKs (Derijard et al., 1995).”
InfluentialMAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis
Kotlyarov, A., Neininger, A., Schubert, C., Eckert, R., Birchmeier, C., Volk, H.-D., & Gaestel, M. (1999) · Nature Cell Biology · doi:10.1038/10061 · Cited by 763
Matsuzawa, A., Saegusa, K., Noguchi, T., Sadamitsu, C., Nishitoh, H., Nagai, S., Koyasu, S., Matsumoto, K., Takeda, K., & Ichijo, H. (2005) · Nature Immunology · doi:10.1038/ni1200 · Cited by 667 · cited 2×
“For example, ASK1 may be activated by endotoxin, inflammatory cytokines, and oxidative stress (Matsuzawa et al., 2005), while MLK3 and TAK1 can be activated by transforming growth factor- and LPS (Lee et al., 2000; Kim et al., 2004).”
Atomic structure of the MAP kinase ERK2 at 2.3 A resolution
Zhang, F., Strand, A., Robbins, D., Cobb, M. H., & Goldsmith, E. J. (1994) · Nature · doi:10.1038/367704a0 · Cited by 592
MAPKAP kinases — MKs — two's company, three's a crowd
Gaestel, M. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1834 · Cited by 413 · cited 6×
“Several reports have also implicated MK-2 in the regulation of hnRNP A0 and HUR (Rousseau et al., 2002; Gaestel, 2006), although a specific link between MK2-induced phosphorylation and function is lacking.”
BackgroundInfluentialAlternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases
Salvador, J. M., Mittelstadt, P. R., Guszczynski, T., Copeland, T. D., Yamaguchi, H., Appella, E., Fornace, A. J., & Ashwell, J. D. (2005) · Nature Immunology · doi:10.1038/ni1177 · Cited by 306 · cited 1×
“This ZAP70mediated phosphorylation promotes autophosphorylation of the TGY motif and subsequent activation of p38 MAPK (Salvador et al., 2005).”
BackgroundChang, C.-I., Xu, B.-E., Akella, R., Cobb, M. H., & Goldsmith, E. J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00525-7 · Cited by 302
p38 Mitogen-activated Protein Kinase Activates Peroxisome Proliferator-activated Receptor α
Barger, P. M., Browning, A. C., Garner, A. N., & Kelly, D. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105945200 · Cited by 260 · cited 1×
“…kinases, and other enzymes. p38 MAPK can directly phosphorylate several transcription factors, such as myocyte-specific enhancer binding factor 2C (MEF2C), CHOP, PPAR co-activator 1, peroxisome proliferator-activated receptor , and p53 (Wang and Ron, 1996; Han et al., 1997; Barger et al., 2001).”
BackgroundMolecular basis of MAPK-activated protein kinase 2:p38 assembly
White, A., Pargellis, C. A., Studts, J. M., Werneburg, B. G., & Farmer, B. T. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701679104 · Cited by 111 · cited 2×
“This interaction between p38 MAPK and MK-2 has been structurally confirmed in the crystal structure of the non-phosphorylated heterodimeric complex of p38:MK-2 (ter Haar et al., 2007; White et al., 2007).”
BackgroundCrystal Structure of the P38α-MAPKAP Kinase 2 Heterodimer
Haar, E. T., Prabakhar, P., Liu, X., & Lepre, C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611165200 · Cited by 100 · cited 1×
“This interaction between p38 MAPK and MK-2 has been structurally confirmed in the crystal structure of the non-phosphorylated heterodimeric complex of p38:MK-2 (ter Haar et al., 2007; White et al., 2007).”
BackgroundHo, D. T., Bardwell, A. J., Grewal, S., Iverson, C., & Bardwell, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601010200 · Cited by 70 · cited 3×
“No other uses without permission.jdr.sagepub.comDownloaded from International and American Associations for Dental Research activate p38 MAPK isoforms, while MKK4 and MKK7 activate JNK. MKK4 has also been shown to phosphorylate p38 MAPK in specific cells under the direction of select stimuli (Brancho et al., 2003).”
BackgroundUnderwood, K. W., Parris, K. D., Federico, E., Mosyak, L., Czerwinski, R. M., Shane, T., Taylor, M., Svenson, K., Liu, Y., Hsiao, C.-L., et al. (2003) · Structure · doi:10.1016/s0969-2126(03)00092-3 · Cited by 62
Cited by
TNF-α signalling and inflammation: interactions between old acquaintances
Zelová, H., & Hošek, J. (2013) · Inflammation Research · doi:10.1007/s00011-013-0633-0 · Cited by 853
p38MAPK: stress responses from molecular mechanisms to therapeutics
Coulthard, L. R., White, D. E., Jones, D. L., McDermott, M. F., & Burchill, S. A. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.06.005 · Cited by 691
The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer
Yong, H.-Y., Koh, M.-S., & Moon, A. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903321490 · Cited by 422
Yang, Y., Kim, S. C., Yu, T., Yi, Y.-S., Rhee, M. H., Sung, G.-H., Yoo, B. C., & Cho, J. Y. (2014) · Mediators of Inflammation · doi:10.1155/2014/352371 · Cited by 406
Targeting protein kinases in central nervous system disorders
Chico, L. K., Van Eldik, L. J., & Watterson, D. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2999 · Cited by 298
Metadata
- Authors
- Schindler, J. F., Monahan, J. B., & Smith, W. G.
- Venue
- Journal of Dental Research
- Publisher
- SAGE Publications
- Published
- 2007-09
- Volume
- 86
- Issue
- 9
- Pages
- 800-811
- ISSN
- 0022-0345 (ISSN-L)
- 1544-0591
- OpenAlex
- W2001186853
- Cited by
- 227
- References
- 13
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.